Mudit Tyagi

3.2k total citations · 1 hit paper
48 papers, 2.6k citations indexed

About

Mudit Tyagi is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mudit Tyagi has authored 48 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Virology, 24 papers in Molecular Biology and 21 papers in Infectious Diseases. Recurrent topics in Mudit Tyagi's work include HIV Research and Treatment (37 papers), HIV/AIDS drug development and treatment (15 papers) and Immune Cell Function and Interaction (13 papers). Mudit Tyagi is often cited by papers focused on HIV Research and Treatment (37 papers), HIV/AIDS drug development and treatment (15 papers) and Immune Cell Function and Interaction (13 papers). Mudit Tyagi collaborates with scholars based in United States, Italy and Uganda. Mudit Tyagi's co-authors include Mauro Giacca, Jonathan Karn, Marco Rusnati, Marco Presta, Joseph Hokello, R. J. Pearson, María Inés Gutiérrez, Giuseppe Marzio, Adhikarimayum Lakhikumar Sharma and Richard D. Pearson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Journal of Biological Chemistry.

In The Last Decade

Mudit Tyagi

46 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans

2001 602 citations Mudit Tyagi, Marco Rusnati et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mudit Tyagi United States	23	1.5k	1.5k	750	654	288	48	2.6k
Nathalie J. Arhel France	23	894 0.6×	1.1k 0.8×	615 0.8×	443 0.7×	207 0.7×	50	1.9k
Mathias Viard United States	33	1.9k 1.3×	825 0.6×	512 0.7×	612 0.9×	129 0.4×	70	2.9k
Ursula Dietrich Germany	31	1.8k 1.2×	1.3k 0.9×	1.1k 1.5×	524 0.8×	474 1.6×	105	3.5k
Suryaram Gummuluru United States	28	1.2k 0.8×	1.2k 0.9×	674 0.9×	1.3k 2.0×	116 0.4×	65	3.0k
Natalia de Val United States	32	2.1k 1.4×	2.3k 1.6×	914 1.2×	1.1k 1.7×	207 0.7×	56	3.9k
Emily J. Platt United States	22	675 0.4×	2.3k 1.6×	1.1k 1.5×	1.3k 2.0×	162 0.6×	34	2.8k
Nathan M. Sherer United States	24	1.2k 0.8×	829 0.6×	411 0.5×	624 1.0×	371 1.3×	65	2.7k
F. Hill United Kingdom	25	1.4k 0.9×	517 0.4×	421 0.6×	440 0.7×	280 1.0×	59	2.5k
Leopold Kong United States	28	1.2k 0.8×	1.2k 0.8×	437 0.6×	609 0.9×	108 0.4×	34	2.9k
Stefanie Sowinski United States	13	1.3k 0.9×	633 0.4×	340 0.5×	986 1.5×	112 0.4×	14	2.8k

Countries citing papers authored by Mudit Tyagi

Since Specialization

Citations

This map shows the geographic impact of Mudit Tyagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mudit Tyagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mudit Tyagi more than expected).

Fields of papers citing papers by Mudit Tyagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mudit Tyagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mudit Tyagi. The network helps show where Mudit Tyagi may publish in the future.

Co-authorship network of co-authors of Mudit Tyagi

This figure shows the co-authorship network connecting the top 25 collaborators of Mudit Tyagi. A scholar is included among the top collaborators of Mudit Tyagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mudit Tyagi. Mudit Tyagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nag, Aditi, et al.. (2025). Exploring dual applications of gliptins: A potential host-targeted strategy for diabetes and COVID-19 co-morbidity. Medical Hypotheses. 197. 111602–111602.

Hokello, Joseph, et al.. (2023). Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers. Viruses. 15(6). 1362–1362. 4 indexed citations

Sharma, Adhikarimayum Lakhikumar, et al.. (2022). HIV Promotes Neurocognitive Impairment by Damaging the Hippocampal Microvessels. Molecular Neurobiology. 59(8). 4966–4986. 8 indexed citations

Sharma, Adhikarimayum Lakhikumar, Joseph Hokello, & Mudit Tyagi. (2021). Circumcision as an Intervening Strategy against HIV Acquisition in the Male Genital Tract. Pathogens. 10(7). 806–806. 5 indexed citations

Zicari, Sonia, Adhikarimayum Lakhikumar Sharma, Larisa Dubrovsky, et al.. (2020). DNA dependent protein kinase (DNA-PK) enhances HIV transcription by promoting RNA polymerase II activity and recruitment of transcription machinery at HIV LTR. Oncotarget. 11(7). 699–726. 24 indexed citations

Sharma, Adhikarimayum Lakhikumar, et al.. (2020). Shedding Light on the Role of Extracellular Vesicles in HIV Infection and Wound Healing. Viruses. 12(6). 584–584. 16 indexed citations

Hokello, Joseph, Adhikarimayum Lakhikumar Sharma, Girish C. Shukla, & Mudit Tyagi. (2020). A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19. Annals of Translational Medicine. 8(24). 1686–1686. 6 indexed citations

Guo, Jia, et al.. (2018). Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages. Virology. 518. 241–252. 14 indexed citations

Tyagi, Mudit, Michael Bukrinsky, & Gary L. Simon. (2016). Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse. Current HIV Research. 14(5). 442–454. 27 indexed citations

10.

Farley, Kalamo, Nazira El‐Hage, Benjamas Aiamkitsumrit, et al.. (2015). Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. Virology. 483. 185–202. 24 indexed citations

11.

Tyagi, Mudit & Michael Bukrinsky. (2012). Human Immunodeficiency Virus (HIV) Latency: The Major Hurdle in HIV Eradication. Molecular Medicine. 18(7). 1096–1108. 57 indexed citations

12.

Lalonde, Matthew S., Michael A. Lobritz, Annette N. Ratcliff, et al.. (2011). Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA. PLoS Pathogens. 7(5). e1002038–e1002038. 62 indexed citations

13.

Tyagi, Mudit & Fabio Romerio. (2011). Models of HIV-1 Persistence in the CD4+ T Cell Compartment: Past, Present and Future. Current HIV Research. 9(8). 579–587. 11 indexed citations

14.

Tyagi, Mudit, R. J. Pearson, & Jonathan Karn. (2010). Establishment of HIV Latency in Primary CD4⁺Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction. Journal of Virology. 84(13). 6425–6437. 209 indexed citations

15.

Nojima, Masanori, Ye-Hong Huang, Mudit Tyagi, Hung‐Ying Kao, & Koh Fujinaga. (2008). The Positive Transcription Elongation Factor b Is an Essential Cofactor for the Activation of Transcription by Myocyte Enhancer Factor 2. Journal of Molecular Biology. 382(2). 275–287. 22 indexed citations

16.

Tyagi, Mudit & Jonathan Karn. (2007). CBF‐1 promotes transcriptional silencing during the establishment of HIV‐1 latency. The EMBO Journal. 26(24). 4985–4995. 192 indexed citations

17.

Silhol, Michelle, Mudit Tyagi, Mauro Giacca, Bernard Lebleu, & Éric Vivès. (2002). Different mechanisms for cellular internalization of the HIV‐1 Tat‐derived cell penetrating peptide and recombinant proteins fused to Tat. European Journal of Biochemistry. 269(2). 494–501. 220 indexed citations

18.

Tyagi, Mudit, Marco Rusnati, Marco Presta, & Mauro Giacca. (2001). Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans. Journal of Biological Chemistry. 276(5). 3254–3261. 602 indexed citations breakdown →

19.

Marcello, Alessandro, Aldo Ferrari, Mudit Tyagi, et al.. (2001). Visualization of in Vivo Direct Interaction between HIV-1 TAT and Human Cyclin T1 in Specific Subcellular Compartments by Fluorescence Resonance Energy Transfer. Journal of Biological Chemistry. 276(42). 39220–39225. 45 indexed citations

20.

Rusnati, Marco, Giulia Taraboletti, Chiara Urbinati, et al.. (2000). Thrombospondin‐1/HIV‐1 Tat protein interaction: modulation of the biological activity of extracellular Tat. The FASEB Journal. 14(13). 1917–1930. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact